Rapport Therapeutics SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

424B5Oct. 27, 2026, 4:55 p.m. ETView on SEC.gov
424B5Oct. 27, 2026, 4:52 p.m. ETView on SEC.gov
4Oct. 23, 2026, 4:30 p.m. ETView on SEC.gov
4Oct. 23, 2026, 4:01 p.m. ETView on SEC.gov
4Oct. 22, 2026, 4:57 p.m. ETView on SEC.gov
4Oct. 22, 2026, 4:56 p.m. ETView on SEC.gov
4Oct. 22, 2026, 4:56 p.m. ETView on SEC.gov
4Oct. 22, 2026, 4:56 p.m. ETView on SEC.gov
4Oct. 21, 2026, 5:46 p.m. ETView on SEC.gov
8-KOct. 20, 2026, 6:05 a.m. ETView on SEC.gov
Regulation FD disclosure · Other events · Financial statements and exhibits
AI summary, unreviewedRapport Therapeutics Reports Positive Phase 2 Bipolar Mania Results for RAP-219, Meeting Primary Endpoint at 3.1-Point YMRS Improvement (p=0.045)
4Oct. 8, 2026, 4:07 p.m. ETView on SEC.gov
4Oct. 1, 2026, 4:30 p.m. ETView on SEC.gov
4Sept. 24, 2026, 4:05 p.m. ETView on SEC.gov
4Sept. 9, 2026, 4:05 p.m. ETView on SEC.gov
4Aug. 26, 2026, 4:05 p.m. ETView on SEC.gov
4Aug. 26, 2026, 4 p.m. ETView on SEC.gov
4Aug. 20, 2026, 4:09 p.m. ETView on SEC.gov
SCHEDULE 13G/AAug. 14, 2026, 4:15 p.m. ETView on SEC.gov
SCHEDULE 13G/AAug. 14, 2026, 2:05 p.m. ETView on SEC.gov
SCHEDULE 13G/AAug. 12, 2026, 10:28 a.m. ETView on SEC.gov
4Aug. 12, 2026, 4:35 p.m. ETView on SEC.gov
10-QAug. 5, 2026, 7:30 a.m. ETView on SEC.gov
8-KAug. 5, 2026, 7:17 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
4July 29, 2026, 4:05 p.m. ETView on SEC.gov